ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

Practice Management Giant US Oncology To Sell Practices Back to Physicians.

October 5, 2001

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004